Bank of New York Mellon’s Disc Medicine IRON Stock Holding History
Bought
Maintained
Sold
Other funds holding IRON
IGAM
Bank of New York Mellon's IRON Position: Q2 2026 in Review
Bank of New York Mellon reduced its Disc Medicine (IRON) stake by 0.12% in Q2 2026, selling an estimated $16.6K and leaving 204,727 shares worth $15M. The position accounts for ﹤0.01% of the portfolio, ranked #1807.
Bank of New York Mellon first reported a position in IRON in Q1 2021 and has held it in 20 quarters since. 82 funds tracked by Wall St. Rank hold IRON as of Q2 2026.
- Bank of New York Mellon held 204,727 shares of Disc Medicine worth $15M as of Q2 2026.
- Bank of New York Mellon sold 241 Disc Medicine shares in Q2 2026, an estimated $16.6K.
- Disc Medicine made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #1807 holding.
- Bank of New York Mellon first reported a position in Disc Medicine in Q1 2021 and has held it in 20 quarters since.
- 82 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.